ORGANOGENESIS HOLDINGS INC CLASS A (ORGO) — insider trading
Health Care · NASDAQ
ORGANOGENESIS HOLDINGS INC CLASS A (ORGO) has 19 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 19 (latest 2026-03-09).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Driscoll Michael Joseph | Director | Open-market purchase | 10,000 | $2.67 | $26.7K | Form 4 |
| 2026-03-09 | Leibowitz Arthur S | Director | Open-market purchase | 5,000 | $2.68 | $13.4K | Form 4 |
| 2026-03-01 | Cavorsi Robert | Officer (Vice President, Strategy) | Shares withheld for taxes / exercise cost | 700 | $3.21 | $2.2K | Form 4 |
| 2026-02-18 | Freedman Lori | Officer (Chief Admin. and Legal Officer) | Shares withheld for taxes / exercise cost | 14,411 | $3.84 | $55.3K | Form 4/A |
| 2026-02-18 | Freedman Lori | Officer (Chief Admin. and Legal Officer) | Grant / award / vesting | 43,212 | — | $0 | Form 4/A |
| 2026-02-18 | Cavorsi Robert | Officer (Vice President, Strategy) | Shares withheld for taxes / exercise cost | 5,487 | $3.84 | $21.1K | Form 4/A |
| 2026-02-18 | Cavorsi Robert | Officer (Vice President, Strategy) | Grant / award / vesting | 16,454 | — | $0 | Form 4/A |
| 2026-02-18 | Francisco David | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 14,687 | $3.84 | $56.4K | Form 4/A |
| 2026-02-18 | Francisco David | Officer (Chief Financial Officer) | Grant / award / vesting | 44,040 | — | $0 | Form 4/A |
| 2026-02-18 | Bilbo Patrick | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 16,375 | $3.84 | $62.9K | Form 4/A |
| 2026-02-18 | Bilbo Patrick | Officer (Chief Operating Officer) | Grant / award / vesting | 49,102 | — | $0 | Form 4/A |
| 2026-02-18 | Grow Brian | Officer (Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 11,887 | $3.84 | $45.6K | Form 4/A |
| 2026-02-18 | Grow Brian | Officer (Chief Commercial Officer) | Grant / award / vesting | 48,818 | — | $0 | Form 4/A |
| 2026-02-18 | Gillheeney Gary S. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 91,311 | $3.84 | $350.6K | Form 4/A |
| 2026-02-18 | Gillheeney Gary S. | Director, Officer (President and CEO) | Grant / award / vesting | 188,856 | — | $0 | Form 4/A |
| 2026-02-18 | Montecalvo Antonio S. | Officer (Vice President, Health Policy) | Shares withheld for taxes / exercise cost | 3,778 | $3.84 | $14.5K | Form 4/A |
| 2026-02-18 | Montecalvo Antonio S. | Officer (Vice President, Health Policy) | Grant / award / vesting | 11,330 | — | $0 | Form 4/A |
| 2025-01-10 | Grow Brian | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 958 | — | $0 | Form 4 |
| 2025-01-10 | Grow Brian | Officer (Chief Commercial Officer) | Option exercise / conversion | 958 | $1.24 | $1.2K | Form 4 |
Ask the chat about ORGO's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ORGANOGENESIS HOLDINGS INC CLASS A (ORGO).
Last updated 2026-03-09 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.